Andy Patamawenu
Overview
    Explore the profile of Andy Patamawenu including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              5
            
            
              Citations
              155
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Migueles S, Nettere D, Gavil N, Wang L, Toulmin S, Kelly E, et al.
  
  
    Science
    . 2023 Dec;
          382(6676):1270-1276.
    
    PMID: 38096385
  
  
          Current HIV vaccines designed to stimulate CD8 T cells have failed to induce immunologic control upon infection. The functions of vaccine-induced HIV-specific CD8 T cells were investigated here in detail....
      
2.
        
    
    Matsuda K, Migueles S, Huang J, Bolkhovitinov L, Stuccio S, Griesman T, et al.
  
  
    J Clin Invest
    . 2021 Feb;
          131(5).
    
    PMID: 33529172
  
  
          BACKGROUNDTo understand the features of a replicating vaccine that might drive potent and durable immune responses to transgene-encoded antigens, we tested a replication-competent adenovirus type 4 encoding influenza virus H5...
      
3.
        
    
    Migueles S, Mendoza D, Zimmerman M, Martins K, Toulmin S, Kelly E, et al.
  
  
    EBioMedicine
    . 2015 Jul;
          2(1):46-58.
    
    PMID: 26137533
  
  
          Understanding natural immunologic control over Human Immunodeficiency Virus (HIV)-1 replication, as occurs in rare long-term nonprogressors/elite controllers (LTNP/EC), should inform the design of efficacious HIV vaccines and immunotherapies. Durable control...
      
4.
        
    
    Smalls-Mantey A, Doria-Rose N, Klein R, Patamawenu A, Migueles S, Ko S, et al.
  
  
    J Virol
    . 2012 Jun;
          86(16):8672-80.
    
    PMID: 22674985
  
  
          Antibody (Ab)-dependent cellular cytotoxicity (ADCC) is thought to potentially play a role in vaccine-induced protection from HIV-1. The characteristics of such antibodies remain incompletely understood. Furthermore, correlates between ADCC and...
      
5.
        
    
    Migueles S, Rood J, Berkley A, Guo T, Mendoza D, Patamawenu A, et al.
  
  
    PLoS Pathog
    . 2011 Mar;
          7(2):e1002002.
    
    PMID: 21383976
  
  
          If future HIV vaccine design strategies are to succeed, improved understanding of the mechanisms underlying protection from infection or immune control over HIV replication remains essential. Increased cytotoxic capacity of...